Long-term application of haloperidol: effect of anticholinergic treatment on the rate of dopamine synthesis.
D000818:Animals; D001590:Benztropine / Q000494:pharmacology; D002421:Caudate Nucleus / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000096:biosynthesis*; D006220:Haloperidol / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D009714:Nucleus Accumbens / Q000378:metabolism; D010276:Parasympatholytics / Q000494:pharmacology*; D011699:Putamen / Q000378:metabolism; D051381:Rats; D013997:Time Factors
D010276:Parasympatholytics; D001590:Benztropine; D004295:Dihydroxyphenylalanine; D006220:Haloperidol; D004298:Dopamine